No disclosed counterparties: MATV.
None
| Stage | ECVT | % of rev | MATV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $250M | 100.00% | $532M | 100.00% | MATV ×2.13 |
| Gross profit | $50M | 19.94% | $113M | 21.31% | MATV +1.4pp |
| Operating income | $19M | 7.75% | $35M | 6.64% | ECVT +1.1pp |
| Pre-tax income | $15M | 5.96% | $7M | 1.28% | ECVT +4.7pp |
| Net income | $8M | 3.15% | $4M | 0.68% | ECVT +2.5pp |
| Stage | ECVT | MATV | Gap · A − B |
|---|---|---|---|
| Revenue | $250M100.00% | $532M100.00% | MATV ×2.13 |
| Gross profit | 19.94%$50M | 21.31%$113M | MATV +1.4pp |
| Operating income | 7.75%$19M | 6.64%$35M | ECVT +1.1pp |
| Pre-tax income | 5.96%$15M | 1.28%$7M | ECVT +4.7pp |
| Net income | 3.15%$8M | 0.68%$4M | ECVT +2.5pp |